Nutra Pharma Corp
Business Description
Nutra Pharma Corp is a biopharmaceutical company that specializes in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, autoimmune, and infectious diseases. The company has its headquarters in Coral Springs, Florida and was founded in 2000.
The primary focus of Nutra Pharma Corp is to develop and market innovative products derived from natural sources that address significant unmet medical needs. They have developed a unique drug pipeline that includes both prescription and over-the-counter (OTC) products. The company*s research and development efforts are centered on the advancement of their proprietary drug candidates, targeting specific medical conditions.
One of the notable technologies that Nutra Pharma Corp has acquired is the licensed rights to a drug known as RPI-78M. RPI-78M is a low-dose formulation of the FDA-approved drug, RPI-78, which is used in the treatment of chronic pain. The company has developed an injectable form of RPI-78M, which has shown potential in the management of chronic pain associated with conditions like Multiple Sclerosis and Adrenomyeloneuropathy.
Apart from RPI-78M, Nutra Pharma Corp has also developed a line of OTC products under the brand name Nyloxin. Nyloxin is a safe and non-addictive topical gel that provides relief from various types of pain, including arthritis, back pain, joint pain, and muscle pain. It is derived from cobra venom and has been proven to provide effective analgesic properties without the side effects commonly associated with other pain medications.
Furthermore, Nutra Pharma Corp is actively involved in the research and development of treatments for infectious diseases. They have developed a technology called ReceptoPharm that aims to treat serious viral and neurological disorders such as HIV/AIDS and Multiple Sclerosis. This innovative technology focuses on the utilization of antiviral peptides and proteins that can inhibit the replication of viruses in the body.
In addition to their pharmaceutical products, Nutra Pharma Corp also has a subsidiary called Designer Diagnostics, which provides rapid diagnostic testing solutions for infectious diseases. This subsidiary offers a wide range of diagnostic kits for the detection of various viral and bacterial infections, including Zika Virus, Dengue Fever, Tuberculosis, and Chikungunya.
Nutra Pharma Corp is committed to improving the quality of life for patients suffering from debilitating diseases and conditions. They strive to bring innovative, safe, and effective treatments to the market and work towards expanding their product portfolio through strategic acquisitions and collaborations with other pharmaceutical companies. With their diverse range of products and dedicated research efforts, Nutra Pharma Corp aims to become a leader in the field of biopharmaceuticals.
|